Drugs / Magnesium Diasporal
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07149649 | Aug 2026 → Jan 2031 expected | non-small cell lung carcinoma | Swiss Cancer Institute | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesium Diasporal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07149649 ↗ |
| Known as | MAGNESIUM LEVULINATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1235931 ↗ |
| Modality | Small molecule | — CHEMBL1235931 ↗ |
| Route | Intravenous | “intravenous at day 1 of each therapy cycle” NCT07149649 ↗ |